RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells

Atsushi Naito, Hirofumi Yamamoto, Yoshinori Kagawa, Yoko Naito, Daisuke Okuzaki, Keisuke Otani, Yoriko Iwamoto, Sakae Maeda, Junichi Kikuta, Keizo Nishikawa, Mamoru Uemura, Junichi Nishimura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Hideshi Ishii, Yuichiro Doki, Masaki Mori, Masaru Ishii

Research output: Contribution to journalArticle

Abstract

Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G1 retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a "fluorescence ubiquitin-based cell cycle indicator" identified a characteristic population that is viable but remains in the G1 phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G1-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G1 population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G1 population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.

Original languageEnglish
Pages (from-to)6326-6337
Number of pages12
JournalJournal of Biological Chemistry
Volume290
Issue number10
DOIs
Publication statusPublished - Mar 6 2015

Fingerprint

Chemotherapy
Population Dynamics
Colorectal Neoplasms
Cell Cycle
Cells
HCT116 Cells
Drug Therapy
Ubiquitin
Neoplasms
Cell Line
G1 Phase
Population Characteristics
Microarray Analysis
Ligases
Mitosis
Bearings (structural)
Fluorescence
Microarrays
Refractory materials
Tumors

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells. / Naito, Atsushi; Yamamoto, Hirofumi; Kagawa, Yoshinori; Naito, Yoko; Okuzaki, Daisuke; Otani, Keisuke; Iwamoto, Yoriko; Maeda, Sakae; Kikuta, Junichi; Nishikawa, Keizo; Uemura, Mamoru; Nishimura, Junichi; Hata, Taishi; Takemasa, Ichiro; Mizushima, Tsunekazu; Ishii, Hideshi; Doki, Yuichiro; Mori, Masaki; Ishii, Masaru.

In: Journal of Biological Chemistry, Vol. 290, No. 10, 06.03.2015, p. 6326-6337.

Research output: Contribution to journalArticle

Naito, A, Yamamoto, H, Kagawa, Y, Naito, Y, Okuzaki, D, Otani, K, Iwamoto, Y, Maeda, S, Kikuta, J, Nishikawa, K, Uemura, M, Nishimura, J, Hata, T, Takemasa, I, Mizushima, T, Ishii, H, Doki, Y, Mori, M & Ishii, M 2015, 'RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells', Journal of Biological Chemistry, vol. 290, no. 10, pp. 6326-6337. https://doi.org/10.1074/jbc.M114.614859
Naito, Atsushi ; Yamamoto, Hirofumi ; Kagawa, Yoshinori ; Naito, Yoko ; Okuzaki, Daisuke ; Otani, Keisuke ; Iwamoto, Yoriko ; Maeda, Sakae ; Kikuta, Junichi ; Nishikawa, Keizo ; Uemura, Mamoru ; Nishimura, Junichi ; Hata, Taishi ; Takemasa, Ichiro ; Mizushima, Tsunekazu ; Ishii, Hideshi ; Doki, Yuichiro ; Mori, Masaki ; Ishii, Masaru. / RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells. In: Journal of Biological Chemistry. 2015 ; Vol. 290, No. 10. pp. 6326-6337.
@article{131da5ed57af4451a6927d4e47fca203,
title = "RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells",
abstract = "Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G1 retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a {"}fluorescence ubiquitin-based cell cycle indicator{"} identified a characteristic population that is viable but remains in the G1 phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G1-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G1 population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G1 population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.",
author = "Atsushi Naito and Hirofumi Yamamoto and Yoshinori Kagawa and Yoko Naito and Daisuke Okuzaki and Keisuke Otani and Yoriko Iwamoto and Sakae Maeda and Junichi Kikuta and Keizo Nishikawa and Mamoru Uemura and Junichi Nishimura and Taishi Hata and Ichiro Takemasa and Tsunekazu Mizushima and Hideshi Ishii and Yuichiro Doki and Masaki Mori and Masaru Ishii",
year = "2015",
month = "3",
day = "6",
doi = "10.1074/jbc.M114.614859",
language = "English",
volume = "290",
pages = "6326--6337",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "10",

}

TY - JOUR

T1 - RFPL4A increases the G1 population and decreases sensitivity to chemotherapy in human colorectal cancer cells

AU - Naito, Atsushi

AU - Yamamoto, Hirofumi

AU - Kagawa, Yoshinori

AU - Naito, Yoko

AU - Okuzaki, Daisuke

AU - Otani, Keisuke

AU - Iwamoto, Yoriko

AU - Maeda, Sakae

AU - Kikuta, Junichi

AU - Nishikawa, Keizo

AU - Uemura, Mamoru

AU - Nishimura, Junichi

AU - Hata, Taishi

AU - Takemasa, Ichiro

AU - Mizushima, Tsunekazu

AU - Ishii, Hideshi

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Ishii, Masaru

PY - 2015/3/6

Y1 - 2015/3/6

N2 - Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G1 retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a "fluorescence ubiquitin-based cell cycle indicator" identified a characteristic population that is viable but remains in the G1 phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G1-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G1 population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G1 population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.

AB - Cell cycle-arrested cancer cells are resistant to conventional chemotherapy that acts on the mitotic phases of the cell cycle, although the molecular mechanisms involved in halting cell cycle progression remain unclear. Here, we demonstrated that RFPL4A, an uncharacterized ubiquitin ligase, induced G1 retention and thus conferred decreased sensitivity to chemotherapy in the human colorectal cancer cell line, HCT116. Long term time lapse observations in HCT116 cells bearing a "fluorescence ubiquitin-based cell cycle indicator" identified a characteristic population that is viable but remains in the G1 phase for an extended period of time (up to 56 h). Microarray analyses showed that expression of RFPL4A was significantly up-regulated in these G1-arrested cells, not only in HCT116 cells but also in other cancer cell lines, and overexpression of RFPL4A increased the G1 population and decreased sensitivity to chemotherapy. However, knockdown of RFPL4A expression caused the cells to resume mitosis and induced their susceptibility to anti-cancer drugs in vitro and in vivo. These results indicate that RFPL4A is a novel factor that increases the G1 population and decreases sensitivity to chemotherapy and thus may be a promising therapeutic target for refractory tumor conditions.

UR - http://www.scopus.com/inward/record.url?scp=84924959504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924959504&partnerID=8YFLogxK

U2 - 10.1074/jbc.M114.614859

DO - 10.1074/jbc.M114.614859

M3 - Article

C2 - 25605732

AN - SCOPUS:84924959504

VL - 290

SP - 6326

EP - 6337

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 10

ER -